Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2012

Dec 14, 2012

30786_dirs_2012-12-14_ed81d6db-5e5b-472e-8a84-1399086f4cbb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2012-12-14

Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-12-03 Bio-Rad B Common Stock G 120 Acquired 97068 Direct
2012-12-14 Bio-Rad B Common Stock M 61487 $36.00 Acquired 158555 Direct
2012-12-14 Bio-Rad B Common Stock F 39889 $105.50 Disposed 118666 Direct
2012-12-03 Bio-Rad B Common Stock G 120 Acquired 12266 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-12-14 Non-Qualified Stock Option (right to buy) $36.00 M 61487 Disposed 2013-02-05 Bio-Rad B Common Stock (61487) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The shares are held by a limited partnership of which the reporting person is a limited partner.

F4: The stock option vested in five equal annual installments beginning on February 5, 2004.